CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vitrolife AB is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vitrolife AB
Gustaf Werners gata 2, Vastra Frolunda
Phone: +46 317218000p:+46 317218000 GOETEBORG, 421 32  Sweden Ticker: VITRVITR
Business Summary
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes---Yes

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board JonSigurdsson 67 8/1/2023 5/5/2015
President, Chief Executive Officer BronwynBrophy 50 8/1/2023 8/1/2023
Chief Financial Officer PatrikTolf 53 1/1/2022 1/1/2022
10 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
UNISENSE A/S Tueager 1 Aarhus N DK
OCTAX Microscience GmbH Dr.-Pauling-Str.9 Bruckberg Germany
eFertility International B.V. Floridalaan 8 IJSSELSTEIN Netherlands
Igenomix SLU Calle Narcis Monturiol I Estarriol 11 Paterna Spain
Igenomix US, LLC 7955 NW 12th Street Miami FL United States

Business Names
Business Name
0GN0
0YAY
A.T.S. Srl
24 additional Business Names available in full report.

General Information
Number of Employees: 1,100 (As of 9/30/2024)
Outstanding Shares: 135,394,622 (As of 9/30/2024)
Shareholders: 17,860
Stock Exchange: STO
Fax Number: +46 317218099


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024